课题基金 / 基金详情

RISEDRONATE TO TREAT WOMEN WITH OSTEOPOROSIS RELATED VERTEBRAL DEFORMITIES

RISEDRONATE TO TREAT WOMEN WITH OSTEOPOROSIS RELATED VERTEBRAL DEFORMITIES
利塞膦酸钠治疗患有骨质疏松症相关椎骨畸形的女性
批准号：
6291101
负责人：
C. CONRAD JOHNSTON
金额：
$0.04万
依托单位：
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6291101
关键词：
clinical research clinical trials drug screening /evaluation female human subject human therapy evaluation osteoporosis placebos postmenopause skeletal disorder chemotherapy spine disorder women's health

项目摘要

项目成果

C. CONRAD JOHNSTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A randomized, double-blind, placebo-controlled, multi-center parallel group study to determine the efficacy and safety of Risedronate in the treatment of postmenopausal women with established osteoporosis-related vertebral deformities
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROLE OF SEX STEROIDS IN AGE-RELATED BONE LOSS
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED STUDY ON EFFICACY OF IBANDRONATE
RALOXIFENE HCL AND PLACEBO IN PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSALS
海外基金